Can doctors predict which children recover slowly after bile duct cyst surgery?

NCT ID NCT07800169

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This study looks back at the medical records of 550 children who had surgery to remove a common bile duct cyst, a condition that can block bile flow and damage the liver. Researchers want to identify which factors, such as age or lab results, are linked to faster recovery of bowel function and shorter hospital stays. They will also build a risk prediction model to help doctors plan better care before and after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this analysis could help doctors predict which children may have slower recovery after surgery, allowing them to tailor care and improve outcomes.
What could go wrong
Because this is a retrospective review of medical records, it can only show associations, not cause and effect. The findings may not apply to all children or hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

550 people

The number who actually took part.

Started

Jan 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study enrolled patients admitted between 2017 and 2025 to the Department of Hepatobiliary Surgery at Wuhan Children's Hospital, Anhui Provincial Children's Hospital, Shanxi Provincial Children's Hospital, Tianjin Children's Hospital, or the Affiliated Hospital of Zunyi Medical University. All patients were scheduled to receive either laparoscopic cholecystectomy and choledochal cyst excision, end-to-side jejunojejunal Y anastomosis and hepaticojejunostomy, or robot-assisted laparoscopic cholecystectomy and choledochal cyst excision, end-to-side jejunojejunal Y anastomosis and hepaticojejunostomy. The target population was patients aged 0-16 years who were definitively diagnosed with choledochal cyst via preoperative pathology or imaging examination, and met the indications for elective surgery. All enrolled patients must have complete perioperative clinical data, and be able to cooperate with postoperative follow-up observation until discharge.

Ages

1 week to 16 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1\) Age between 0-16 years, meeting the age-based classification criteria for pediatric patients; 2) Diagnosis of common bile duct cyst confirmed by imaging studies (liver and gallbladder ultrasonography, MRCP, or CT), with histological typing performed according to the Todani classification system; 3) First-time surgical resection of the common bile duct cyst combined with radical Roux-en-Y hepatojejunal anastomosis; 4) Complete clinical medical records, preoperative laboratory test data, intraoperative surgical documentation, postoperative rehabilitation and follow-up data; 5) The study cases are affiliated with respective participating research centers, and inpatient and follow-up data can be readily retrieved. Exclusion Criteria: 1\) Children with severe end-stage liver cirrhosis, irreversible liver failure, or malignant biliary tract tumors; 2) Children with severe multi-organ failure (e.g., cardiac, pulmonary, or renal failure) who cannot be adequately assessed for surgical prognosis; 3) Children undergoing secondary surgery or those with recurrent choledochal cysts; 4) Children who have only undergone palliative stoma creation or percutaneous drainage without receiving radical surgical intervention; 5) Cases in which critical perioperative clinical data are missing, making it impossible to meet the requirements for data analysis.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Choledochal cyst resection are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Wuhan Children'c Hospital

    Wuhan, Hubei, 430016, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.